Key points are not available for this paper at this time.
Design
Review
Risk tools warrant periodic clinical review; leaves open optimal new factors for global validation.
Atherothrombotic disease is now the leading cause of mortality in the world and there are only a few methods available to estimate risk of vascular disease. Vascular disease risk assessment methods have been developed from a variety of population based studies and the most frequently used approaches include algorithms developed by Framingham (USA), Munster (Germany), and SCORE (Europe). The field of risk estimation is dynamic and inclusion of newer factors and populations is under active consideration and methods such as discrimination and calibration are now available to evaluate the use of risk assessment tools across different world regions.
No takes yet. Share an insight, caveat, or question.
Peter W.F. Wilson (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: